| Literature DB >> 24213848 |
F Schirmeister1, R Dieckmann, S Bechlars, N Bier, S M Faruque, E Strauch.
Abstract
Vibrio cholerae belonging to the non-O1, non-O139 serogroups are present in the coastal waters of Germany and in some German and Austrian lakes. These bacteria can cause gastroenteritis and extraintestinal infections, and are transmitted through contaminated food and water. However, non-O1, non-O139 V. cholerae infections are rare in Germany. We studied 18 strains from German and Austrian patients with diarrhea or local infections for their virulence-associated genotype and phenotype to assess their potential for infectivity in anticipation of possible climatic changes that could enhance the transmission of these pathogens. The strains were examined for the presence of genes encoding cholera toxin and toxin-coregulated pilus (TCP), as well as other virulence-associated factors or markers, including hemolysins, repeats-in-toxin (RTX) toxins, Vibrio seventh pandemic islands VSP-1 and VSP-2, and the type III secretion system (TTSS). Phenotypic assays for hemolysin activity, serum resistance, and biofilm formation were also performed. A dendrogram generated by incorporating the results of these analyses revealed genetic differences of the strains correlating with their clinical origin. Non-O1, non-O139 strains from diarrheal patients possessed the TTSS and/or the multifunctional autoprocessing repeats-in-toxin (MARTX) toxin, which were not found in the strains from ear or wound infections. Routine matrix-assisted laser desorption/ionization (MALDI-TOF) mass spectrometry (MS) analysis of all strains provided reliable identification of the species but failed to differentiate between strains or clusters. The results of this study indicate the need for continued surveillance of V. cholerae non-O1, non-O139 in Germany, in view of the predicted increase in the prevalence of Vibrio spp. due to the rise in surface water temperatures.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24213848 PMCID: PMC3996285 DOI: 10.1007/s10096-013-2011-9
Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN: 0934-9723 Impact factor: 3.267
List of non-O1, non-O139 Vibrio cholerae strains and control O1 or O139 strains used in this study
| Strain | Year of isolation | Type of infection | Origin | Source |
|---|---|---|---|---|
| VN-0168 | 2010 | wound infection* | Germany | LAGuS |
| VN-0169 | 2010 | wound infection* | Germany | LAGuS |
| VN-0210 | 2011 | diarrhea/travel disease | Tunisia | RKI |
| VN-0211 | 2011 | diarrhea/travel disease | Italy | RKI |
| VN-0297 | 1995 | otitis | Germany | BfR |
| VN-0298 | 1995 | otitis | Germany | BfR |
| VN-0299 | 1996 | diarrhea/travel disease | Tunisia | BfR |
| VN-0300 | 1999 | diarrhea, peritonitis | unknown | BfR |
| VN-0301 | 2000 | otitis | Austria | BfR |
| VN-0302 | 2012 | diarrhea | Germany | RKI |
| VN-0303 | 2012 | otitis | Hungary | RKI |
| VN-0304 | 2012 | diarrhea/travel disease | Egypt | RKI |
| VN-0305 | 2012 | otitis | Germany | RKI |
| VN-0307 | 2012 | otitis | Germany | RKI |
| VN-0308 | 2012 | diarrhea/travel disease | Romania | RKI |
| VN-0313 | 2000 | otitis | Austria | AGES |
| VN-0314 | 2005 | otitis | Austria | AGES |
| VN-0315 | 2011 | diarrhea/travel disease | Cuba | AGES |
| Control strains | ||||
| NIH35A3 (O1) | 1941 | diarrhea | India | BfR |
| NIH41 (O1) | 1941 | diarrhea | India | BfR |
| 1576 (O1) | 1959 | diarrhea | Thailand | BfR, [ |
| 1360 (O1) | 1959 | diarrhea | Thailand | BfR, [ |
| MO45 (O139) | 1992 | diarrhea | India | BfR |
*Isolates from the same patient
AGES: Austrian Agency for Health and Food Safety, Vienna, Austria
BfR: Federal Institute for Risk Assessment, Berlin, Germany
LAGuS: State Office for Health and Social Affairs, Rostock, Germany
RKI: Robert Koch Institute, Berlin, Germany
Polymerase chain reaction (PCR) primers, targets, and amplicon sizes used for genotyping
| Target gene | Primer | Sequence | Amplicon size (bp) | References |
|---|---|---|---|---|
|
| O139F | AGCCTCTTTATTACGGGTGG | [ | |
|
| O139R | GTCAAACCCGATCGTAAAGG | 449 | [ |
|
| O1F | GTTTCACTGAACAGATGGG | [ | |
|
| O1R | GGTCATCTGTAAGTACAAC | 192 | [ |
|
| ctxA1 | CTCAGACGGGATTTGTTAGGCACG | [ | |
|
| ctxA2 | TCTATCTCTGTAGCCCCTATTACG | 301 | [ |
|
| UtoxF | GASTTTGTTTGGCGYGARCAAGGTT | [ | |
|
| VctoxR | GGTTAGCAACGATGCGTAAG | 640 | [ |
|
| CM32b-F | CGGAACGGCCTGACGTTGCAT | [ | |
|
| 1110F-R | GTAGAAATCTACCGCATGATG | 984 | [ |
|
| 1661F* | TTYATGGAYCARAACAACCC | – | [ |
|
| 1783b* | GGACCTTYAGGNGTTTCGAT | – | [ |
|
| hlyA-489F | GGCAAACAGCGAAACAAATACC | 727/738 | [ |
|
| hlyA-744F | GAGCCGGCATTCATCTGAAT | 481 | [ |
|
| hlyA-1184R | CTCAGCGGGCTAATACGGTTTA | [ | |
|
| tcpA-F_Class-ET | CACGATAAGAAAACCGGTCAAGAG | [ | |
|
| tcpA-R_class | TTACCAAATGCAACGCCGAATG | 620 | [ |
|
| tcpA-R_ET | AATCATGAGTTCAGCTTCCCGC | 453 | [ |
| TTSS | TTSS_vcsC2-A | CGTTACCGATGCTATGGGT | [ | |
| TTSS | TTSS_vcsC2-B | AGAAGTCGGTTGTTTCGGTAA | 535 | [ |
| TTSS | TTSS_vcsN2-A | CAGTTGAGCCAATTCCATT | [ | |
| TTSS | TTSS_vcsN2-B | GACCAAACGAGATAATG | 484 | [ |
| TTSS | TTSS_vspD-A | AACTCGAAGAGCAGAAAAAAGC | [ | |
| TTSS | TTSS_vspD-B | CTTCCCGCTTTTGATGAAATG | 422 | [ |
| TTSS | TTSS_vcsV2-A | TTTGGCTCACTTGATGGG | [ | |
| TTSS | TTSS_vcsV2-B | GCCACATCATTGCTTGCT | 742 | [ |
|
| VC0409-F | ATTCTCGGTATCTTGGCCGTC | [ | |
|
| VC0409-R | ACAAGCAGTTCCAGCAACCC | 459 | [ |
|
| VC-rstR-class-F | CTCATCAGCAAAGCCTCCATC | [ | |
|
| VC-rstR-class-R | TAGCAAATGGTATCGGCGTTG | 241 | [ |
|
| VC1455-F | AGCCAACCAAAGAAAGGCAAT | [ | |
|
| VC1455-R | TCATCTGTGGCCCATCTTCC | 186 | [ |
|
| VC-rstR-calc-F | CCAGCATTTCTGTTTCTTTG | [ | |
|
| VC-rstR-calc-R | GGCAACAAAGCACATTAAAG | 104 | [ |
|
| VCA1111-F | CAACCATGCACTAAATTGCCC | This study | |
|
| VCA1111-R | TGGAAGTCATTACACCCACGC | 526 | This study |
|
| VC-chxA-F | TGTGTGATGATGCTTCTGG | [ | |
|
| VC-chxA-R | TTATTTCAGTTCATCTTTTCGC | 2000 | [ |
|
| VC1451-F | GATTCTTCCGTTCAAGCTCCG | This study | |
|
| VC1451-R | TGGTTCAGGCTGTTGCACAC | 2571 | This study |
|
| VC1450-F | TGCAAATCTCACATTAGCGCA | This study | |
|
| VC1450-R | CCACTGCACCTTTCGGATACA | 430 | This study |
|
| ompU-F | ACGCTGACGGAATCAACCAAAG | [ | |
|
| ompU-R | GCGGAAGTTTGGCTTGAAGTAG | 869 | [ |
|
| zot-F | TCGCTTAACGATGGCGCGTTTT | [ | |
|
| zot-R | AACCCCGTTTCACTTCTACCCA | 947 | [ |
|
| ace-F | TAAGGATGTGCTTATGATGGACACCC | [ | |
|
| ace-R | CGTGATGAATAAAGATACTCATAGG | 289 | [ |
| VSP-1 | Vch-VspI-fo | GCTCTCGCCAGCAAGGAGCTG | [ | |
| VSP-1 | Vch-VspI-re | CCGTCGAAGTGAACGGCGAAC | 1700 | [ |
| VSP-2 | Vch-VspII-fo | TGCCCATTCCGCTAAGTGTTC | [ | |
| VSP-2 | Vch-VspII-re | GCAAAAGCACTGCGTAAACTG | 800 | [ |
*Sequencing primers
Fig. 2Grouping of isolates based on phenotypic and genotypic traits. Similarity patterns were determined by complete linkage using simple matching of binary data (BioNumerics version 6.6.4, Applied Maths, Sint-Martens-Latem, Belgium). For the simplification of interpretation, the results of tcpA (two alleles) and rstR (three alleles) are summarized in one column. О = diarrheagenic strains, Δ = strains from local infections
Fig. 1Tree based on partial rpoB sequences created by the unweighted pair group method analysis (UPGMA) with absolute differences. Similarity is shown in percent
Results of genotyping
| Strain |
|
|
|
|
|
|
|
|
|
|
| VSP-1 | VSP-2 |
|
|
|
|
|
|
|
| TTSS | TTSS | TTSS | TTSS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VN-0168 | − | − | − | + | − | − | − | − | − | − | − | −a | − | + | + | − | + | − | + | − | + | − | − | − | − |
| VN-0169 | − | − | − | + | − | − | − | − | − | − | − | −a | − | + | + | − | + | − | + | − | + | − | − | − | − |
| VN-0210 | − | − | − | + | − | − | − | − | − | − | − | − | − | + | + | − | + | + | + | + | + | − | − | − | − |
| VN-0211 | − | − | − | + | − | − | − | − | − | − | − | +b | − | + | + | − | − | + | + | − | + | + | + | + | + |
| VN-0297 | − | − | − | + | − | − | − | − | − | − | − | − | − | + | + | − | + | − | + | − | + | − | − | − | − |
| VN-0298 | − | − | − | + | − | − | − | − | − | − | − | − | − | + | + | − | + | − | + | − | + | − | − | − | − |
| VN-0299 | − | − | − | + | − | − | − | − | − | − | − | − | − | + | + | − | − | − | + | − | + | + | + | + | + |
| VN-0300 | − | − | − | + | − | − | − | − | − | − | − | −a | − | + | + | − | + | − | + | + | + | + | + | + | + |
| VN-0301 | − | − | − | + | − | − | − | − | − | − | − | − | − | + | + | − | − | − | + | + | − | − | − | − | − |
| VN-0302 | − | − | − | + | − | − | − | − | − | − | − | − | − | + | + | − | − | − | + | − | + | + | + | + | + |
| VN-0303 | − | − | − | + | − | − | − | − | − | − | − | − | − | − | −c | − | − | − | + | − | − | − | − | − | − |
| VN-0304 | − | − | − | + | − | − | − | − | − | − | − | − | +b | + | + | − | − | + | + | − | + | − | − | − | − |
| VN-0305 | − | − | − | + | − | − | − | − | − | − | − | − | − | + | + | − | + | − | + | − | + | − | − | − | − |
| VN-0307 | − | − | − | + | − | − | − | − | − | − | − | − | − | + | + | − | + | − | + | − | + | − | − | − | − |
| VN-0308 | − | − | − | + | − | − | − | − | − | − | − | − | − | + | + | − | − | + | + | − | + | + | + | + | + |
| VN-0313 | − | − | − | + | − | − | − | − | − | − | − | − | − | + | + | − | − | − | + | − | + | − | − | − | − |
| VN-0314 | − | − | − | + | − | − | − | − | − | − | − | − | − | + | + | − | − | − | + | − | + | − | − | − | − |
| VN-0315 | − | − | − | + | − | − | − | − | − | − | − | − | +b | + | + | − | + | + | + | − | + | + | + | + | + |
| NIH35A3 | + | − | + | + | + | + | + | + | + | − | − | − | − | + | − | + | + | − | − | − | + | − | − | − | − |
| NIH41 | + | − | + | + | + | + | + | + | + | − | − | − | − | + | − | + | + | − | − | − | + | − | − | − | − |
| 1576 | + | − | + | + | + | + | + | + | + | − | − | − | − | + | − | + | + | − | − | − | + | − | − | − | − |
| 1360 | + | − | + | + | + | + | + | + | + | − | − | − | − | + | − | + | + | − | − | − | + | − | − | − | − |
| MO45 | − | + | + | + | + | + | − | + | − | + | − | +b | +b | − | + | + | + | + | + | − | + | − | − | − | − |
Absence of VSP-1 and VSP-2 is demonstrated by generating PCR products of 1,700 bp and 800 bp, respectively, as primers bind to genomic sites flanking the islands
aPCR product of ca. 3 kbp
bNo visible PCR product
cOnly 481-bp PCR product visible
Phenotypic characteristics of Vibrio cholerae strains
| Strain | Sucrose | Mannose | Serum resistance | Biofilm formation | Sheep blood agar | Hemolysis (cells) | Hemolysis (supernatant) |
|---|---|---|---|---|---|---|---|
| VN-0168 | + | − | sensitive | intermediate | + | + | + |
| VN-0169 | + | − | sensitive | intermediate | + | + | + |
| VN-0210 | + | + | sensitive | intermediate | + | + | + |
| VN-0211 | + | − | resistant | weak | + | + | + |
| VN-0297 | + | − | intermediate | none | + | + | + |
| VN-0298 | + | − | sensitive | weak | + | + | − |
| VN-0299 | + | − | intermediate | weak | + | + | + |
| VN-0300 | + | + | sensitive | weak | + | + | + |
| VN-0301 | + | − | intermediate | strong | − | + | + |
| VN-0302 | + | − | sensitive | intermediate | + | + | + |
| VN-0303 | + | − | sensitive | weak | + | + | − |
| VN-0304 | + | − | intermediate | none | + | + | − |
| VN-0305 | + | − | sensitive | intermediate | + | + | + |
| VN-0307 | + | − | sensitive | weak | + | + | − |
| VN-0308 | + | − | resistant | weak | + | + | + |
| VN-0313 | + | + | resistant | weak | + | + | + |
| VN-0314 | + | + | sensitive | weak | + | + | + |
| VN-0315 | + | + | sensitive | weak | + | + | + |
| NIH35A3 | + | + | sensitive | none | − | − | + |
| NIH41 | + | + | resistant | intermediate | − | + | + |
| 1576 | + | + | sensitive | none | − | + | + |
| 1360 | + | + | sensitive | none | − | + | + |
| MO45 | + | + | intermediate | none | + | + | + |